Researchers Pinpoint Genes with Key Role in Neuronal Growth and RegenerationFriday, Nov 20, 2009
In a new study funded by the National Institute of Neurological Disorders and Stroke (NINDS), investigators identified a set
of genes that are regulated during development, and that in turn regulate the capacity of nerve cells to grow.

Better Understanding of Newborn Seizures Leads to Potential New TreatmentThursday, Oct 29, 2009
Commonly used anti-seizure medications do not work as effectively in newborns as they do in adults and children. A new study
funded by the National Institute of Neurological Disorders and Stroke (NINDS) helps explain why, and suggests that effective
treatment for newborn seizures could be a matter of repurposing an available drug and using it to supplement conventional
anti-seizure therapies.

Study Calls for Rethinking CT Scans in the ED to Diagnose Children with HeadacheThursday, Oct 29, 2009
When a child is rushed to the emergency room with an acute headache, the goal for both parents and doctors is to determine
if a serious neurological condition might be causing the pain. One option is to perform a computed tomography (CT) scan to
aid diagnosis. But a new study offers evidence that CT scans are of little benefit for diagnosing headache in young children
who have normal neurological exams and no history of serious problems.
Therapy Investigated for ALS May Find New Role in Kennedy’s DiseaseMonday, Oct 26, 2009
A growth factor that has generated tides of hope and disappointment for treating amyotrophic lateral sclerosis (ALS) may turn
out to be an effective therapy for a less common disease, Kennedy’s disease.
Investment in Parkinson’s Disease Data Bank Yields Potential TherapyTuesday, Oct 13, 2009
Individuals with Parkinson’s disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal
fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health.
A clinical trial is under way to examine the safety and potential benefits of supplemental urate elevation for recently diagnosed
Parkinson’s patients who have low urate levels.
NINDS Names Dr. Petra Kaufmann Director of the Office of Clinical ResearchWednesday, Sep 9, 2009
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has named
Petra Kaufmann, M.D., M.Sc., as director of its Office of Clinical Research.
More NINDS News Articles
Qualified media representatives can arrange interviews and photos with NINDS researchers and administrators. E-Mail or call (301) 496-5751.
Office of Communications And Public Liaison
Building 31, Room 8A-16
31 Center Drive MSC 2540
P.O. Box 5801
Bethesda, MD 20824